‘Second Generation’ Dihydropyridine Calcium Antagonists: Greater Vascular Selectivity and Some Unique Applications

Drugs

Volumn 34, Issue 5, 1987, Pages 578-598

  Freedman, Donna D ^a   Waters, David D ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FELODIPINE; NEW DRUG; NICARDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE;

ANGINA PECTORIS; ARTERIOSCLEROSIS; CALCIUM ANTAGONISM; CARDIOVASCULAR SYSTEM; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DRUG COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HUMAN; ISCHEMIA; PERIPHERAL VASCULAR SYSTEM; REVIEW; THERAPY; VASODILATATION;

ANIMAL; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIHYDROPYRIDINES; HUMAN;

EID: 0023206059     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-198734050-00005     Document Type: Review

References (209)

1. Renal actions of calcium antagonists. Abstract
2. Comparative trial of felodipine and nifedipine in refractory hypertension
3. Role of calcium antagonists in cerebral arterial spasm
4. Cerebral arterial spasm — a controlled trial of nimodipine in patients with subarachnoid hemorrhage
5. The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons
6. Nicardipine in models of myocardial infarction
7. Nicardipine and phenytoin prevention of cerebral ischemic cell change in a new rat survival model of brief four-vessel occlusion. Abstract
8. Alcohol-induced spasms of cerebral blood vessels: relation to cerebrovascular accidents and sudden death
9. Short-term effects of felodipine, a new dihydropyridine, in hypertension
10. Felodipine a calcium-inhibiting vasodilator in refractory hypertension
11. Nicardipine: beneficial effect on cardiac function and energy conservation during coronary reperfusion of the rat working heart
12. Nicardipine hydrochloride in essential hypertension — a controlled study
13. Preventive nimodipine and acute aneurysm surgery
14. Prevention of symptomatic vasospasm by topically applied nimodipine
15. Intraoperative topical nimodipine after aneurysm clipping
16. Electrophysiologic effects of felodipine
17. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine
18. Effects of nicardipine hydrochloride in cardiac failure: a dose titration and tolerance study
19. Hemodynamic study of nifedipine administration in hypertensive patients
20. Regional vasodilating and cardiac effects of nicardipine in anaesthetized open chest dogs
21. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris
22. The effect of a new calcium antagonist, felodipine, on pulmonary hypertension and gas exchange in chronic obstructive lung disease
23. Mechanism of action of calcium-channel-blocking agents
24. Effects of nitrendipine and nisoldipine on arterial pressure and regional hemodynamics in the conscious rat
25. Analysis of extent and duration of the anti-ischemic effects of nisoldipine: results of a double-blind, randomized crossover, placebo-controlled, acute and long-term study. Abstract
26. Nimodipine versus flunarizine in common migraine: a controlled pilot trial
27. Acute and chronic effects of a new calcium inhibitor, nicardipine, on renal haemodynamics in hypertension
28. Twice-daily nicardipine in the treatment of essential hypertension
29. Comparative calcium entry blocking properties of nicardipine, nifedipine and PY I08068 on cardiac and vascular smooth muscle
30. Effect of felodipine and propranolol on muscle and skin arteries in hypertensive patients
31. Long-term experience of felodipine in combination with β-blockade and diuretics in refractory hypertension
32. Felodipine vs hydralazine: a controlled trial as third line therapy in hypertension
33. Cardiovascular, baroreflex and humoral responses in hypertensive patients during nicardipine therapy
34. Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina
35. Comparative effects of nicardipine, hydrochloride and hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind parallel study
36. Acute hemodynamic effects of felodipine during beta-blockade in patients with coronary artery disease
37. Nisoldipin in der Therapie der essentiellen Hypertonie
38. Energy conservation by nisoldipine in ischaemic heart
39. Effects of felodipine on renal function in animals
40. Cardiac and regional hemodynamic properties of nicardipine, a new dihydropyridine derivative in conscious dogs. Abstract
41. Acute diuretic/natriuretic properties of felodipine in man
42. Antianginal efficacy of nifedipine with and without a beta blocker, studied with exercise test. A double-randomized subacute study
43. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure
44. Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure
45. Antihypertensive effects of felodipine compared to placebo
46. Effects of felodipine on systemic and coronary haemodynamics in patients with angina pectoris
47. Acute haemodynamic effects of felodipine in congestive heart failure
48. No adverse effects from high doses of felodipine to patients with coronary heart disease
49. The effectiveness of two different treatments with nicardipine, a new calcium antagonist, on infarct size following coronary artery occlusion in dogs. Abstract
50. 2+ antagonists: potent inhibitors of secretions from normal and transformed pituitary cells
51. Factors influencing the hypotensive effects of calcium antagonists
52. Effect of nicardipine in elderly hypertensive patients
53. Clinical and systemic hemodynamic effects of nitrendipine
54. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, β-receptor blockers, and their combination in hypertensive patients
55. Crossover comparison of nitrendipine with propranolol in patients with essential hypertension
56. Nicardipine for angina pectoris at rest and coronary arterial spasm
57. Nimodipine, a new calcium antagonist, in the prophylactic treatment of migraine
58. The effects of nimodipine on the clinical course of patients with acute ischemic stroke
59. Short- and long-term treatment of stable effort angina with nicardipine, a new calcium entry blocker: a double-blind, placebo-controlled, randomised, repeated cross-over study
60. Early aneurysm operation and vasospasm
61. Nitrendipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension
62. Intracarotid slow bolus injection of nimodipine during angiography for treatment of cerebral vasospasm after SAH
63. Nitrendipine vs long-acting nifedipine in mild, moderate and severe hypertension
64. Experimental cerebral vasospasm in cats: modification by a new synthetic vasodilator YC-93. Abstract
65. Antihypertensive effect of felodipine combined with β-blockade. A comparison between 2 and 3 daily dosages
66. The antihypertensive effects and pharmacokinetics of nitrendipine in patients with essential hypertension
67. Effect of the calcium antagonist, nimodipine, on cerebral blood flow and metabolism in the primate
68. The effects of a calcium antagonist, nimodipine, upon physiological responses of the cerebral vasculature and its possible influence upon focal cerebral ischaemia
69. Effects of nicardipine, a dihydropyridine calcium antagonist, on regional myocardial blood flow, myocardial oxygen tension, and electrical abnormalities in acute coronary artery occlusions in dogs
70. Efficacy of nimodipine in the prophylaxis of migraine
71. Effects of nimodipine on cerebral blood flow
72. Renal effects of felodipine in hypertensive patients with reduced renal function
73. Selective effects of different calcium antagonists on the peripheral circulation
74. ++ channel blocker, on blood pressure and serum lipids
75. Synthesis of new water-soluble dihydropyridine vasodilators
76. Hemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris
77. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study
78. Electrophysiological effects of felodipine in combination with metoprolol
79. Nisoldipine: a new, more selective calcium channel blocker in cardiac Purkinje fibers
80. Comparative effects of three calcium antagonists, diltiazem, verapamil, and nifedipine, on the sinoatrial and atrioventricular nodes: experimental and clinical studies
81. Pharmacology of a new calcium antagonistic compound, isobutyl methyl l,4-dihydro-2,6-dimethyl-4-(2 nitrophenyl)-3, 5-pyridenedicarboxylate (nisoldipine, Bay K 5552)
82. The duration of action of calcium antagonists in vitro: a comparison of nifedipine and nisoldipine (Bay K 5552)
83. Clinical experience with nimodipine in the prophylaxis of neurological deficits after subarachnoid hemorrhage
84. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina
85. Salutary hemodynamic and sustained beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure
86. Effect of nisoldipine on electrophysiologic parameters in patients pretreated with β-blockers
87. Blood pressure, heart rate, and AV conduction in hypertensive patients receiving atenolol
88. Nimodipine treatment of ischemic neurological deficits due to cerebral vasospasm after subarachnoid hemorrhage
89. Treatment of cerebral vasospasm with the calcium influx blocker nimodipine
90. Nimodipine and chronic vasospasm in monkeys: part 2. Pharmacologic studies of vessels in spasm
91. Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study
92. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects
93. Myocardial ischemia during intravenous nicardipine administration
94. Effects of nicardipine on left ventricular function and energetics in man
95. Coronary and systemic hemodynamic effects of nicardipine
96. Selective antagonism of humoral versus neural vasoconstrictor responses by nisoldipine
97. Salutary actions of nimodipine in traumatic shock
98. Felodipine, a new vasodilating drug: blood pressure, cardiac, renal, and humoral effects in hypertensive patients
99. Comparative efficacy of nicardipine hydrochloride and atenolol in the treatment of chronic stable angina
100. The effect of nifedipine on arterial pressure and reflex cardiac control
101. The effect of nicardipine on blood pressures. Its variability and reflex cardiac control
102. Vascular selectivity of felodipine
103. Improvement in exercise performance with nisoldipine, a new second generation calcium blocker, in stable angina pectoris
104. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients
105. Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function
106. Calcium channel blockade with nitrendipine: effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans
107. Regression of structural cardiovascular changes by antihypertensive therapy in spontaneously hypertensive rats
108. Felodipine in hypertension
109. Effects of nicardipine hydrochloride on the conduction system of the heart in man
110. Effect of nisoldipine on the general and coronary hemodynamics of the anesthetized dog
111. Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks
112. The effects of a calcium antagonist (nimodipine) on basal cerebral blood flow and reactivity to various agonists
113. Comparison of nicardipine and propranolol for chronic stable angina pectoris
114. Cerebral blood flow and neurological outcome: a controlled study of nimodipine in patients with subarachnoid hemorrhage
115. Chemistry of nitrendipine and its metabolites
116. Clinical effectiveness of calcium entry blockers in the prophylactic treatment of migraine and cluster headaches
117. Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension
118. Nicardipine vs propranolol in the treatment of essential hypertension: effect on total body elemental composition
119. Assessment of calcium antagonistic properties of nicardipine in cerebral artery and cardiac muscle. Abstract
120. Effects of nicardipine, a new dihydropyridine vasodilator, on coronary circulation and ischemia-induced conduction delay in dogs
121. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension
122. et al. Hemodynamic effects of nifedipine during upright exercise in stable angina pectoris and either normal or severely impaired left ventricular function
123. Haemodynamic effects of short- and long-term administration of felodipine in spontaneously hypertensive rats
124. Nimodipine and chronic vasospasm in monkeys: Part I. Clinical and radiological findings
125. Nimodipine pretreatment reduces infarct size after middle cerebral artery occlusion
126. Treatment of hypertension with nifedipine, a calcium antagonist agent
127. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure
128. A long-term study of the combined antihypertensive action of nitrendipine and metoprolol
129. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far
130. The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects
131. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in stable angina pectoris
132. 3H-nimodipine in human brain
133. Relative potency and selectivity of calcium antagonists used for the treatment of migraine
134. Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease
135. Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness
136. Nicardipine and nifedipine administration selectively improves regional abnormalities in early diastolic filling. Abstract
137. Pharmacokinetics and metabolism of nitrendipine
138. In vitro effects of nicardipine on vascular and cardiac muscle preparations
139. Effect of nicardipine on vertebral blood flow in dogs
140. Effects of calcium channel blockers in pial vascular responses to receptor mediated constrictors
141. Double-blind double-dummy crossover study of the efficacy and safety of nisoldipine (Bay K 5552) versus nifedipine
142. Nicardipine and nifedipine: effects on diuresis and serum aldosterone levels in spontaneously hypertensive rats
143. Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease
144. Calcium antagonism free of negative inotropic effects? A comparison of intracoronary nifedipine and nicardipine. Abstract
145. Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris
146. Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow, and oxygen supply in angina pectoris
147. Effect of nifedipine on A-V conduction as compared with verapamil
148. Efficacy of nitrendipine as baseline and hypertensive therapy
149. Acute hemodynamic effects of nitrendipine and nifedipine in man
150. Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study of the electrophysiological effects of nitrendipine in man
151. Efficacy and safety of nicardipine for chronic, stable angina pectoris: a multicenter randomized trial
152. The ‘in vivo’ and ‘in vitro’ effects of nicardipine on coronary resistance and myocardial performance. Abstract
153. Comparison of nitrendipine combined with low-dose hydrochlorthiazide to hydrochlorthiazide alone in mild to moderate essential hypertension
154. The electrophysiologic effects of nisoldipine in the conscious dog
155. Regional wall motion from radiopaque markers after intravenous and intracoronary injections of nifedipine
156. Influence of intracoronary nifedipine on left ventricular function, coronary vasomobility, and myocardial oxygen consumption
157. Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics
158. Acute haemodynamic effects of felodipine in patients with coronary artery disease
159. Effects of nicardipine on cardiac volume at rest and during exercise-induced angina
160. Haemodynamic effects of nicardipine in acute myocardial infarction
161. Comparative hemodynamic effects of nicardipine and verapamil in coronary artery disease
162. Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine
163. Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension, and related cardiovascular disorders
164. Nimodipine improves cerebral blood flow and neurologic recovery after complete cerebral ischemia in the dog
165. Cerebral blood flow and neurological outcome when nimodipine is given after complete cerebral ischemia in the dog
166. Safety aspects of long-term nitrendipine therapy
167. Pharmacologic studies of the antihypertensive effect of nitrendipine
168. Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm
169. The effect of a calcium channel antagonist, nisoldipine, on the ischemia-induced change of canine sarcolemmal membrane
170. Cardiovascular pharmacology of nicardipine in animals
171. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys, and human patients
172. Relaxation of canine coronary strips by water-soluble 1,4 dihydropyridine derivatives: a structure-activity relationship. Abstract
173. Effects of nimodipine (Bay e 9736) on cerebral circulation in cats
174. Effect of nimodipine, a calcium antagonist, on cerebral vasospasm after subarachnoid hemorrhage in cats
175. Antihypertensive dose-response effects of nicardipine in stable essential hypertension
176. A study of the long-term efficacy and tolerability of oral nicardipine in hypertensive patients
177. Influence of nicardipine on the blood pressure at rest and on the pressor responses to cold, isometric exertion and dynamic exercise in hypertensive patients
178. Nifedipine therapy in angina pectoris: evaluation of safety and side effects
179. Blood pressure and heart rate during treatment with nimodipine in patients with subarachnoid hemorrhage
180. Acute hemodynamic and metabolic effects of felodipine in congestive heart failure
181. Restoration of normal reflex responses to orthostatic stress during felodipine therapy in congestive heart failure
182. Effects of vasodilator treatment with felodipine on hemodynamic responses to treadmill testing in congestive heart failure
183. Clinical experience with long-term nitrendipine treatment in essential hypertension
184. The systemic and coronary hemodynamic effects of felodipine in patients with coronary heart disease
185. Influence of nicardipine on blood pressure, renal function, and plasma aldosterone in normotensive volunteers
186. Antihypertensive and renal effects of nicardipine
187. Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension
188. Is nisoldipine capable of reducing left ventricular preload?
189. Immediate and longer term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease
190. Nitrendipine treatment of mild-to-moderate hypertension
191. Controlled comparison of nitrendipine and placebo in the treatment of hypertension
192. Hemodynamic effects of nisoldipine in chronic congestive heart failure
193. Hemodynamic effects of the new vasodilator drug Bay K 5552 in man
194. Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine): an experimental study. Abstract 7560–84
195. Changes in coronary collateral blood flow produced by nitrendipine, nifedipine and diltiazem
196. The slow-channel calcium blocking agent, nitrendipine, and coronary collateral blood flow
197. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem, and nisoldipine (Bay K 5552), a new dihydropyridine calcium antagonist
198. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade
199. Can a calcium entry blocker retard the progression of coronary atherosclerosis? Design features of a large, randomized, double-blind trial using coronary arteriograms
200. Felodipine as a replacement for minoxidil in the treatment of severe hypertension
201. Effects of chronic nitrendipine on casual (office) and 24-hour ambulatory blood pressure
202. Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits
203. Effects of calcium antagonists, administered as antihypertensive drug, on renal hemodynamics
204. Cerebro-circulatory effects of so called “vasodilators” in the anaesthetised rat
205. Baroreflex setting and sensitivity after acute and chronic nicardipine therapy